报价延迟最少15分钟:2026/03/01 16:25 EST
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
47.51 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
0.69/1.74
|
|
企业价值
57.09B
|
| 资产负债 |
|
每股账面净值
0.16
|
| 现金流量 |
|
现金流量率
0.02
|
| 损益表 |
|
收益
25.51B
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Medline is the largest medical-surgical products and supply chain solutions provider in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families-including front line care, surgical solutions, and laboratory and diagnostics-as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025. |
